Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
09-11 April, 2025
Not Confirmed
Not Confirmed
29-30 March, 2025
Not Confirmed
Not Confirmed
31 March-01 April, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
09-11 April, 2025
Industry Trade Show
Not Confirmed
29-30 March, 2025
Industry Trade Show
Not Confirmed
31 March-01 April, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/our-unmatched-efficiency-and-track-record-of-faster-dmf-filings-give-our-customers-a-critical-competitive-advantage
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/molecular-glue-degraders-lilly-abbvie-sign-billion-dollar-deals-bms-leads-with-three-late-stage-drugs
07 Jan 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/tarsier-pharma-appoints-ashley-kline-as-chief-commercial-officer-expanding-its-us-presence-302344307.html
28 May 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/tarsier-pharma-announces-the-appointment-of-emilee-fulcher-as-vice-president-of-clinical-affairs-302156720.html
16 Jan 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/tarsier-pharma-receives-fda-agreement-under-special-protocol-assessment-spa-for-tarsier-04-phase-3-trial-of-trs01-ophthalmic-solution-for-the-treatment-of-non-infectious-uveitis-including-uveitic-glaucoma-302035761.html
13 Nov 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/tarsier-pharma-announces-successful-type-c-meeting-with-fda-for-trs01-in-noninfectious-uveitis-301985947.html
23 Aug 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/tarsier-pharma-announces-results-from-a-phase-3-clinical-trial-in-subjects-with-noninfectious-anterior-uveitis-including-subjects-with-uveitic-glaucoma-301907809.html
12 Jun 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/tarsier-pharma-announces-publication-of-review-article-on-suppressing-inflammation-for-treating-retinal-blinding-ocular-diseases-highlighting-dazdotuftide-trs-as-a-promising-therapeutic-candidate-301848223.html
ABOUT THIS PAGE